Predictive Risk Factors for Postoperative Pancreatic Fistula After Pancreaticoduodenectomy for Malignancy.

Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Pancreaticoduodenectomy (PD) is a complex procedure performed in patients with malignant or benign tumors of the pancreatic head and periampullary region, associated with high morbidity and mortality. Postoperative pancreatic fistula (POPF) is the most common and clinically significant complication following PD. In this study, the investigators aim to determine the predictive risk factors for clinically related postoperative pancreatic fistula (CR-POPF) in the preoperative, intraoperative and postoperative period in patients that underwent PD. The total number of 100 participants expected to be included in this research who underwent PD between 2025 and 2026.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 75
Healthy Volunteers: f
View:

• Patients with resectable distal common bile duct carcinoma, periampullary carcinoma, duodenal carcinoma, and carcinoma of the head of the pancreas.

• Patients meeting the curative treatment intent in accordance with clinical guidelines:

‣ No evidence of metastasis.

⁃ Radiological non-involvement of superior mesenteric vein \& portal vein.

• American Society of Anesthesiologists (ASA) scores I \& II.

• Patients aged \> 18 years.

• Ability to understand and the willingness to sign a written informed consent document

• Agreement to complete the study

Locations
Other Locations
Egypt
Liver and GIT hospital , Minia University
RECRUITING
Minya
Contact Information
Primary
Saleh K Saleh, MD
salehkhairy@mu.edu.eg
01201765401
Time Frame
Start Date: 2025-06-20
Estimated Completion Date: 2026-07-20
Participants
Target number of participants: 100
Treatments
Other: Clinically relevant postoperative pancreatic fistula
patients who developed clinically relevant postoperative pancreatic fistula after pancreaticoduodenectomy
Sponsors
Leads: Minia University

This content was sourced from clinicaltrials.gov